Cargando…

Novel cancer stem cell targets during epithelial to mesenchymal transition in PTEN-deficient trastuzumab-resistant breast cancer

Continued use of trastuzumab in PTEN-deficient HER2+ breast cancer induces the epithelial-to-mesenchymal transition (EMT), transforms HER2+ to triple negative breast cancer, and expands breast cancer stem cells (BCSCs). Using cancer cell lines with two distinct states, epithelial and mesenchymal, we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Lichao, Burnett, Joseph, Gasparyan, Mari, Xu, Fangying, Jiang, Hui, Lin, Chang-Ching, Myers, Ila, Korkaya, Hasan, Liu, Yajing, Connarn, Jamie, He, Huining, Zhang, Ning, Wicha, Max S., Sun, Duxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239484/ https://www.ncbi.nlm.nih.gov/pubmed/27285982 http://dx.doi.org/10.18632/oncotarget.9839

Ejemplares similares

Trastuzumab resistance induces EMT to transform HER2(+) PTEN(−) to a triple negative breast cancer that requires unique treatment options
por: Burnett, Joseph P., et al.
Publicado: (2015)

MEOX1 Promotes Tumor Progression and Predicts Poor Prognosis in Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2019)

CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer
por: Sun, Lichao, et al.
Publicado: (2016)

Regulation of Mammary Stem/Progenitor Cells by PTEN/Akt/β-Catenin Signaling
por: Korkaya, Hasan, et al.
Publicado: (2009)

Lin28 and HER2: Two stem cell regulators conspire to drive aggressive breast cancer
por: Malik, Fayaz, et al.
Publicado: (2012)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Plasticity and Potency of Mammary Stem Cell Subsets During Mammary Gland Development
por: Lee, Eunmi, et al.
Publicado: (2019)

SOCS3-mediated regulation of inflammatory cytokines in PTEN and p53 inactivated triple negative breast cancer model
por: Kim, Gwangil, et al.
Publicado: (2014)

Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer
por: Sun, Lichao, et al.
Publicado: (2017)

Association between expression of Carboxypeptidase 4 and stem cell markers and their clinical significance in liver cancer development
por: Sun, Lichao, et al.
Publicado: (2017)

Serum carboxypeptidaseA4 levels predict liver metastasis in colorectal carcinoma
por: Sun, Lichao, et al.
Publicado: (2016)

Engineering exosomes as refined biological nanoplatforms for drug delivery
por: Luan, Xin, et al.
Publicado: (2017)

PTEN loss and level of HER2 amplification is associated with trastuzumab resistance and prognosis in HER2-positive gastric cancer
por: Kim, Chan, et al.
Publicado: (2017)

Carboxypeptidase A4 negatively correlates with p53 expression and regulates the stemness of breast cancer cells
por: Wang, Yipeng, et al.
Publicado: (2021)

MiR-221 promotes trastuzumab-resistance and metastasis in HER2-positive breast cancers by targeting PTEN
por: Ye, Xingming, et al.
Publicado: (2014)

PTEN expression as a predictor for the response to trastuzumab-based therapy in Her-2 overexpressing metastatic breast cancer
por: Gschwantler-Kaulich, Daphne, et al.
Publicado: (2017)

Identification of non‐reported bupropion metabolites in human plasma
por: Connarn, Jamie N., et al.
Publicado: (2016)

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer
por: Fujita, T, et al.
Publicado: (2006)

Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6–Abundant Breast Cancer Cells by Regulating γ-Secretase–Mediated Notch1 Activation in Caveolae()()
por: Hsu, En-Chi, et al.
Publicado: (2015)

Cancer stem cell heterogeneity in hereditary breast cancer
por: Wicha, Max S
Publicado: (2008)

S100A8 promotes epithelial‐mesenchymal transition and metastasis under TGF‐β/USF2 axis in colorectal cancer
por: Li, Si, et al.
Publicado: (2021)

PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma
por: Yokoyama, Daiju, et al.
Publicado: (2021)

Trastuzumab deruxtecan for breast cancer
Publicado: (2022)

Development of 'synthetic lethal' strategies to target BRCA1-deficient breast cancer
por: Wicha, Max S
Publicado: (2009)

MTDH mediates trastuzumab resistance in HER2 positive breast cancer by decreasing PTEN expression through an NFκB-dependent pathway
por: Du, Cheng, et al.
Publicado: (2014)

Metabolic plasticity of cancer stem cells
por: Luo, Ming, et al.
Publicado: (2015)

Migratory gene expression signature predicts poor patient outcome: Are cancer stem cells to blame?
por: Wicha, Max S
Publicado: (2012)

The uterine epithelial loss of Pten is inefficient to induce endometrial cancer with intact stromal Pten
por: Liang, Xiaohuan, et al.
Publicado: (2018)

Gasdermin D in Different Subcellular Locations Predicts Diverse Progression, Immune Microenvironment and Prognosis in Colorectal Cancer
por: Wang, Jiahui, et al.
Publicado: (2021)

PTEN and Gynecological Cancers
por: Nero, Camilla, et al.
Publicado: (2019)

Chemokines and cellular plasticity of ovarian cancer stem cells
por: Zou, Weiping, et al.
Publicado: (2015)

An Integrative Analysis of PIK3CA Mutation, PTEN, and INPP4B Expression in Terms of Trastuzumab Efficacy in HER2-Positive Breast Cancer
por: Sueta, Aiko, et al.
Publicado: (2014)

PTENα functions as an immune suppressor and promotes immune resistance in PTEN-mutant cancer
por: Sun, Yizhe, et al.
Publicado: (2021)

Tumor-derived exosomes: Nanovesicles made by cancer cells to promote cancer metastasis
por: Chen, Hongwei, et al.
Publicado: (2021)

The PTEN Conundrum: How to Target PTEN-Deficient Prostate Cancer
por: Turnham, Daniel J., et al.
Publicado: (2020)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014)

Editorial: The Tumor Microenvironment: Recent Advances and Novel Therapeutic Approaches
por: Korkaya, Hasan, et al.
Publicado: (2020)

Mammary stem cell number as a determinate of breast cancer risk
por: Ginestier, Christophe, et al.
Publicado: (2007)

Trastuzumab-Coated Nanoparticles Loaded With Docetaxel for Breast Cancer Therapy
por: Zhang, Xueyan, et al.
Publicado: (2019)

Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
por: Park, Y H, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_681i2596q1qdqe7sdkh12ig0vv